Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections
Canan Asli UtineYeditepe University, Department of Ophthalmology, Istanbul, Turkey and Ocular Surface Disease and Dry Eye Clinic, Cornea and External Disease Service, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USAAbstract: Azithromycin is an azalide tha...
Guardado en:
Autor principal: | Utine CA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a993340aa4c94f4084a85d2aeaaa5a9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Azithromycin in DuraSite® for the treatment of blepharitis
por: Jodi Luchs
Publicado: (2010) -
Intracorneal ring implantation using Intralase® with partial coverage of the cone in a patient after an alkaline injury
por: Cakir H, et al.
Publicado: (2011) -
Topical azithromycin or ofloxacin for endophthalmitis
por: Stewart ML, et al.
Publicado: (2012) -
PERSIST: Physician's Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
por: Mah F, et al.
Publicado: (2012) -
Fluoroquinolones compared to 1% azithromycin in DuraSite® for bacterial conjunctivitis [from Lichenstein and Granet] and Response to correspondence [from Friedlaender and Protzko] ||FREE PAPER||
por: Steven J Lichtenstein, et al.
Publicado: (2008)